Document is current
Any future updates will be listed below
-
Authors
Saito, Takeshi
Miyamoto, Hiroko
Igarashi, Manabu
Nanbo, Asuka
Hayashi, Risa
Paroha, Ruchi
Siman-Tov, Gavriella
Littlefield, Kirsten
Mori-Kajihara, Akina
Click, Christine
Furuyama, Wakako
Paessler, Slobodan
Maruyama, Junki
Takada, Ayato
-
Funding
Funding for this research was provided by:
Uehara Memorial Foundation
McLaughlin Fellowship Fund
Japan Society for the Promotion of Science (23K27064)
Japan Society for the Promotion of Science (21H02734)
Japan Agency for Medical Research and Development (JP24jf0126002)
Japan Agency for Medical Research and Development (JP24fk0108624)
Institute for Human Infections and Immunity at UTMB
John S. Dunn Foundation
the Cooperative Research Project Program of the National Research Center for the Control and Prevention of Infectious Diseases and Tropical Disease at the Institute of Tropical Medicine
Chemo-Sero-Therapeutic Research Institute (2023a018)
- License Information
-
More Information
Article History
Received: 2 October 2025
Accepted: 10 December 2025
First Online: 27 December 2025
Competing interests
: T.S., M.I., J.M., and A.T. are inventors on a patent application filed jointly by the University of Texas Medical Branch and Hokkaido University that covers monoclonal antibodies described in this study (Patent application no. 63/575,085). All other authors declare no competing interests.
